•  5
    Addressing organ shortage: An automatic organ procurement model as a proposal
    with Marina Morla-González, Clara Moya-Guillem, David Rodríguez-Arias, Alberto Molina-Pérez, and Iván Ortega-Deballon
    Clinical Ethics 147775092110114. forthcoming.
    Organ shortage constitutes an unsolved problem for every country that offers transplantation as a therapeutic option. Besides the largely implemented donation model and the eventually implemented market model, a theorized automatic organ procurement model has raised a rich debate in the legal, medical and bioethical community, since it could show a higher potential to solve organ shortage. In this paper, we study the main arguments for and against this model. We show how, in the light of empiric…Read more
  •  4
    Gene Editing from the Perspective of Spanish Law
    with Carlos M. Romeo-Casabona and Aliuska Duardo Sánchez
    In Jochen Taupitz & Silvia Deuring (eds.), Rechtliche Aspekte der Genom-Editierung an der Menschlichen Keimbahn : A Comparative Legal Study, Springer Berlin Heidelberg. pp. 389-411. 2020.
    Gene editing is a particularly attractive subject in the Spanish context because it was precisely a scientist of this nationality -Professor Juan Francisco Martínez Mojica, at the University of Alicante-, who was the first to name and identify the function of this region of DNA present in some bacteria and archeas that acts as an immune mechanism against viruses and which has given rise to the gene editing technique known as CRISPR-Cas9. Martínez Mojica discovered that some bacteria and archeas …Read more
  •  8
    Should we have a right to refuse diagnostics and treatment planning by artificial intelligence?
    Medicine, Health Care and Philosophy 23 (2): 247-252. 2020.
    Should we be allowed to refuse any involvement of artificial intelligence technology in diagnosis and treatment planning? This is the relevant question posed by Ploug and Holm in a recent article in Medicine, Health Care and Philosophy. In this article, I adhere to their conclusions, but not necessarily to the rationale that supports them. First, I argue that the idea that we should recognize this right on the basis of a rational interest defence is not plausible, unless we are willing to judge …Read more
  • Ethics and Law for Chemical, Biological, Radiological, Nuclear & Explosive Crises (edited book)
    with Dónal P. O’Mathúna
    Springer Verlag. 2019.
    This book provides a current analysis of the legal and ethical challenges in preparing for and responding to chemical, biological, radiological, nuclear and explosive crises. From past events like the Chernobyl nuclear incident in Russia or the Bhopal chemical calamity in India, to the more recent tsunami and nuclear accident in Japan or the Ebola crisis in Africa, and with the on-going threat of bioterrorism, the need to be ready to respond to CBRNE crises is uncontroversial. What is controvers…Read more
  •  8
    Regulating germline editing in assisted reproductive technology: An EU cross‐disciplinary perspective
    with Ana Nordberg, Timo Minssen, Oliver Feeney, Lucia Galvagni, and Kirmo Wartiovaara
    Bioethics 34 (1): 16-32. 2020.
  •  8
    Should we use human germline genome modification only when serious diseases are involved? This belief is the underlying factor in the article written by Kleiderman, Ravitsky and Knoppers to which I now respond. In my opinion, the answer to this question should be negative. In this paper, I attempt to show that there are no good reasons to think that this technology should be limited to serious diseases once it is sufficiently proven to be safe and efficient. In fact, opting otherwise would negat…Read more
  •  20
    Obsolescence Is Not a Good Reason to Oppose All Types of Enhancement
    American Journal of Bioethics 19 (7): 49-50. 2019.
    Volume 19, Issue 7, July 2019, Page 49-50.
  • ¿ Derechos para los animales?
    Dilemata 1 (1). 2009.